Trends among health professionals on pediatric vaccination. Impact of its modification. Bayamo. 2016-2019
Keywords:
Vaccination, Immunization, Vaccine contraindications, Vaccine delay.Abstract
In Cuba, getting vaccinated is a safe act. Ensuring that this remains the case, making each vaccine truly immunizing, preventing outbreaks of infectious diseases, and providing safety for vaccination depends on the knowledge of the health professional. In order to evaluate the effectiveness of an educational strategy on pediatric vaccination, aimed at primary health care professionals in Bayamo between 2016 and 2019, this research was carried out. The quasi-experimental study included design, application in 181 professionals and evaluation of the strategy. The dependent variable was level of knowledge and the independent variable was educational strategy, which dealt with contraindications, false contraindications (colds, concomitance with antibiotics) and factors that modify the immunogenicity of vaccination (steroids, immunomodulators, blood and derivatives). The level of knowledge about the topics before and after the intervention, the recovery of unvaccinated children and of non-immunizing vaccination was evaluated. The Wilcoxon signed rank test with a confidence index of 95% was used. Initially, the inadequate level of knowledge predominated around 70 (%), which decreased significantly. Twelve unvaccinated children and 60 non-immunizing vaccinations were recovered. The knowledge problems were detected in areas that do not imply danger to life or compromise safety or numerical vaccination coverage. Research has a preventive focus and increases the quality and effectiveness of vaccination. The cognitive level of the professionals was positively modified and the number of children with delay, inadequate contraindication or non-immunizing vaccination decreased. The educational strategy was considered effective.
Downloads
References
1. Karafillaki E, Dinca I, Apfel F, Cecconi S, Wűrz A, Ttakacs J, et.al. Vaccine hesitancy among healthcare workers in europe: a qualitative study. Vaccine 2016; 34(41): 5013-20.
2. Sanders R. 16th Meeting of the European Technical Advisory Group of Experts on Immunization (ETAGE). [Internet]. Copenhagen, Denmark: WHO Regional Office for Europe; 2017. [citado 5/8/2019]. Disponible en: https://www.euro.who.int/__data/assets/pdf_file/0008/333791/ETAGE-16-report.pdf
3. Comité Asesor de Vacunas (CAV-AEP). Manual de Vacunas en línea de la AEP. [Internet]. Madrid: AEP; 2018. [citado 29/4/2018]. Disponible en: https://vacunasaep.org/documentos/manual/manual-de-vacunas
4. OMS. Cobertura vacunal. OMS. [Internet]. 2020 [citado 29/4/2020]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/immunization-coverage
5. World Health Organization. Vaccine safety communication in the digital age. 2018 meeting report, Veyrier-du-Lac, France. WHO [Internet]. 2019 [citado 29/4/2020]. Disponible en: https://apps.who.int/iris/handle/10665/311961
6. Kernéis S, Jacquet C, Bannay A, May T, Launay O, Verger P, et.al. Vaccine education of medical students: a nationwide cross-sectional survey. Am J Prev Med 2017; 53(3): e97-e104.
7. World Health Organization. Global vaccine safety blueprint 2.0 background research. WHO. [Internet]. 2019 [citado 29/4/2020]. Disponible en: https://www.who.int/vaccine_safety/publications/2019_Landscape_Analysis.pdf
8. ONEI. Anuario estadístico Granma 2015. [Internet]. Granma: ONEI; 2016. [citado 7/8/2019]. Disponible en: http://www.onei.gob.cu/sites/default/files/anuario_est_provincial/00granma.pdf
9. Borges Acosta O, Hernández Montoya N. Nivel de conocimiento del programa ampliado de inmunización de algunos profesionales y técnicos. Rev Cubana Hig Epidemiol 1984; 22(1): 106-11.
10. Ministerio de Salud Pública de Cuba. Dirección de docencia médica. Plan de estudio D para la carrera de medicina. La Habana: Editorial Ciencias Médicas; 2017.
11. Moreno Pérez D, Álvarez García FJ, Álvarez Aldeán J, Cilleruelo Ortega MJ, Garcés Sánchez M, García Sánchez N, et al. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2019. An Pediatr (Barc) 2019; 90(1): 56.e1-56.e9.
12. Pahud B, Pallotto EK. Rotavirus immunization for hospitalized infants: Are we there yet? Pediatrics 2018; 141(1): e20173499.
13. Hofstetter AM, Lacombe K, Klein EJ, Jones C, Strelitz B, Jacobson E, et al. Risk of rotavirus nosocomial spread after inpatient pentavalent rotavirus vaccination. Pediatrics. 2018; 141(1): e20171110.
14. Rivero I, Raguindin PF, Buttler R, Martinon Torres F. False Vaccine contraindications among healthcare providers in Europe.A short survey among members of The European Society of Pediatric Infectious Diseases. Pediatr Infec Dis J 2019; 38(9): 974-76.
15. Centers for Disease Control and Prevention. Contraindications and precautions. Vaccine recommendations and Guidelines of the ACIP. CDC. [Internet]. 2019 [citado 29/4/2020]. Disponible en: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html
16. Comité Asesor de Vacunas (CAV-AEP). Seguridad de las vacunas. Contraindicaciones y precauciones. Capítulo 3. En su: Manual de vacunas en línea de la AEP. [Internet]. Madrid: AEP; 2020. [citado 24/1/2020]. Disponible en: http://vacunasaep.org/documentos/manual/cap-3
17. Arístegui Fernández J, Ruiz Contreras J, Hernández Sampelayo T, Moreno Pérez D, Varandas L, Falleiros Arlant LH, Brea del Castillo J. Documento de consenso sobre la vacunación de niños inmunodeprimidos. México Documents. [Internet]. 2019 [citado 29/4/2020]. Disponible en: https://vdocuments.mx/autores-arstegui-fernndez-j-ruiz-contreras-j-documento-de-consenso.html
18. Comité Asesor de Vacunas (CAV-AEP). Vacunación en niños prematuros. Capítulo 10. En su: Manual de Vacunas en línea de la AEP. [Internet]. Madrid: AEP; 2020. [citado 29/4/2020]. Disponible en: https://vacunasaep.org/documentos/manual/cap10
19. Samundio Domínguez GC, Corre Fretes AL, Ortíz Cuquejo LM, Mujica Chaparro P. Retraso del esquema vacunal en niños menores de 5 años en zona marginal. Rev. Nac. (Itauguá) 2017; 9(1): 35-48.
20. Martinon Torres F, Rivero-Calle I. Vaccine Safety and False Contraindication to Vaccination. Training Manual. World Health Organization. [Internet]. 2017 [citado 29/4/2020]. Disponible en: https://www.euro.who.int/__data/assets/pdf_file/0009/351927/WHO-Vaccine-Manual.pdf
21. Tippins A, Leidner AJ, Meghani M, Griffin A, Helgenberger L, Nyaku M, Underwood JM. Timeliness of childhood vaccination in the Federated States of Micronesia. Vaccine 2017; 35(47): 6404-11.
22. Public Health agency of Canada. Canadian Immunization Guide, 2018. Canada.ca. [Internet]. 2018 [citado 29/4/2020]. Disponible en: https://www.canada.ca/en/publichealth/services/canadian-immunizationguide.html
23. Macías Abraham C, Castro Pacheco BL, González Alemán M, Varcárcel Sánchez MA, Noda Albelo A, Marsán Suárez V, et al. Inmunización del enfermo inmunocomprometido en Cuba. Consenso de criterios. Rev Cubana Hematol Inmunol Hemoter 2013; 29(1): 48-58.
24. Wolf E, Rowhani-Rahbar A, Duchin J, Dehart MP, Opel D. The challenges in measuring local immunization coverage: a statewide case study. Pediatrics 2016; 137(5): e20153755.
25. Mbengue MAS, Mboup A, Ly ID, Faye A, Camara FBN, Thiam M, et al. Vaccination coverage and immunization timeliness among children aged 12-23 months in senegal: a kaplan-meier and cox regression analysis approach. Pan Afr Med J 2017; 27(Suppl 3): 8.
26. Kroger AT, Duchin J, Vázquez M. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). [Internet]. 2018 [citado 29/4/2020]. Disponible en: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf

Downloads
Published
How to Cite
Issue
Section
License
Avisos de derechos de autor propuestos por Creative Commons
1. Política propuesta para revistas que ofrecen acceso abierto
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).